Literature DB >> 16272929

Histologic otosclerosis is associated with the presence of measles virus in the stapes footplate.

Tamás Karosi1, József Kónya, Mihály Petkó, István Sziklai.   

Abstract

HYPOTHESIS: Persistent measles virus infection of the otic capsule is presumed to be one of the etiologic factors in otosclerosis. The viral pathogenesis of otosclerosis could be established only by correlative analysis: histologic examination of the stapes footplates and reverse-transcriptase polymerase chain reaction amplification of the viral RNA. At present, histologic analysis of the removed stapes footplates is the only appropriate method of distinguishing otosclerotic and nonotosclerotic stapes fixations.
BACKGROUND: The presence of measles virus was shown in otosclerotic patients by reverse-transcriptase polymerase chain reaction amplification of the viral RNA and detecting the viral proteins by immunohistochemistry.
METHODS: Nucleic acids (mRNA, vRNA, and DNA) were extracted from ankylotic stapes footplates of stapes fixation patients (n = 44). Measles virus genomic nucleoprotein RNA was amplified by seminested reverse-transcriptase polymerase chain reaction. Amplification results were correlated to postoperative histologic findings.
RESULTS: Measles virus RNA was detectable only in histologically otosclerotic stapes footplates (n = 32). Histology for virus-negative footplates (n = 12) excluded otosclerosis. Virus-negative stapes footplates showed annular calcification (n = 8), bone resorption with increased numbers of hemosiderophages (n = 2), and mononuclear cell infiltration with osteolysis (n = 2).
CONCLUSION: Stapes ankylosis is a heterogenous disease causing conductive hearing loss with different causes. Nonotosclerotic stapes fixations may belong to degenerative disorders with variable histopathology. Otosclerosis is an inflammatory disease resulting from persisting measles virus infection of the otic capsule.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272929     DOI: 10.1097/01.mao.0000169304.72519.d2

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  8 in total

Review 1.  Etiopathogenesis of otosclerosis.

Authors:  Tamás Karosi; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

2.  The influence of measles vaccination on the incidence of otosclerosis in Germany.

Authors:  Wolfgang Arnold; Raymonde Busch; Andreas Arnold; Björn Ritscher; Albrecht Neiss; Hans Peter Niedermeyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-13       Impact factor: 2.503

Review 3.  Perspectives of pharmacological treatment in otosclerosis.

Authors:  Balázs Liktor; Zoltán Szekanecz; Tamás József Batta; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

Review 4.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

5.  Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis.

Authors:  Małgorzata Potocka-Bakłażec; Monika Sakowicz-Burkiewicz; Jerzy Kuczkowski; Tadeusz Pawełczyk; Czesław Stankiewicz; Wojciech Sierszeń; Zbigniew Jankowski; Jacek Buczny
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-28       Impact factor: 2.503

6.  Audiological profile of asymptomatic Covid-19 PCR-positive cases.

Authors:  M W M Mustafa
Journal:  Am J Otolaryngol       Date:  2020-04-10       Impact factor: 1.808

Review 7.  Embryonic Origins of Virus-Induced Hearing Loss: Overview of Molecular Etiology.

Authors:  Maryam Karimi-Boroujeni; Ali Zahedi-Amiri; Kevin M Coombs
Journal:  Viruses       Date:  2021-01-06       Impact factor: 5.048

Review 8.  Viral causes of hearing loss: a review for hearing health professionals.

Authors:  Brandon E Cohen; Anne Durstenfeld; Pamela C Roehm
Journal:  Trends Hear       Date:  2014-07-29       Impact factor: 3.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.